Be in your moment
Thousands of women living with metastatic breast cancer (mBC) are living in the moment—and taking IBRANCE®.
IBRANCE is the #1 prescribed, FDA-approved oral combination treatment for HR+, HER2- mBC.
IBRANCE is the #1 prescribed, FDA-approved oral combination treatment for HR+, HER2- mBC.
HR+ = hormone receptor-positive
HER2- = human epidermal growth
What is IBRANCE? IBRANCE 125 mg capsules and tablets are a prescription medicine used in adults to treat HR+, HER2- breast cancer that has spread to other parts of the body (metastatic) in combination with an aromatase inhibitor as the first hormonal based therapy, or fulvestrant in people with disease progression following hormonal therapy.
Support And Information For Those Newly Diagnosed With Metastatic Breast Cancer
An mBC diagnosis can be overwhelming and leave you feeling like your world has been turned upside down. Take a moment to hear how Norma, an IBRANCE Ambassador, coped with the news of her diagnosis. Also, explore the resources tailored for newly diagnosed mBC patients.
Ambassadors were asked to share their personal stories about IBRANCE. All content was accurate at the time of publication and may have since changed.
Get To Know Women Taking IBRANCE
Gain strength and inspiration from women who’ve been prescribed IBRANCE. Their caregivers have thoughts to share, as well. Hear the stories of IBRANCE Ambassadors and learn the ways they’ve adjusted to their new normal.
Savings & Support
Looking For Information & Support?
Throughout your treatment, IBRANCE Answers is your source for helpful tools and information you need to understand treatment with IBRANCE.
Financial Support Resources
If you can’t afford your medicine, we’re here to help. Discover the options that are available for patients.
Additional Support Resources
We can connect you with a dedicated Care Champion who can speak with you one-on-one and offer resources to help with some of your daily challenges.
